[ALA] YoY Quarter Result on 31-Dec-2019 [#Q2]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
30-Dec-2019
Financial Year
2020
Quarter
31-Dec-2019 [#Q2]
Profit Trend
QoQ- -99.97%
YoY- -1,669.89%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 380 23 243 370 427 202 195 11.75%
PBT -4,948 -3,950 -1,756 -7,699 -435 -1,113 -527 45.22%
Tax -1,049 -0 -9 0 0 0 56 -
NP -3,899 -3,950 -1,747 -7,699 -435 -1,113 -471 42.20%
Tax Rate - - - - - - - -
Total Cost 4,279 3,973 1,990 8,069 862 1,315 666 36.32%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -1,027.21 -17,484.78 -720.44 -2,081.94 -101.83 -551.87 -240.94 27.32%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.01 -0.01 -0.01 -0.05 -0.00 -0.02 -0.01 0.00%
EPS Diluted -0.01 -0.01 -0.01 -0.05 -0.00 -0.02 -0.01 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.